Neurocrine Biosciences reported $285.8M in Gross Profit on Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 110.02M 8.15M
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
ALKERMES ALKS:US 250.59M 40.18M
Alnylam Pharmaceuticals ALNY:US $ 190.3M 35.75M
Amgen AMGN:US $ 4889M 478M
Biogen BIIB:US $ 2315.3M 99.4M
Biomarin Pharmaceutical BMRN:US $ 374.63M 8.77M
Dynavax Technologies DVAX:US $ 37.92M 20.79M
Exelixis EXEL:US $ 370.29M 113.26M
Gilead Sciences GILD:US $ 4827M 235M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Halozyme Therapeutics HALO:US $ 113.44M 42.63M
Intercept Pharmaceuticals ICPT:US $ 95.96M 15.11M
Intra Cellular Therapies ITCI:US $ 18.01M 3.58M
IONIS PHARMACEUT IONS:US $ 122.79M 13.76M
Nektar Therapeutics NKTR:US $ 20.66M 2.77M
Neurocrine Biosciences NBIX:US $ 285.8M 52.1M
Pfizer PFE:US $ 11985M 1575M
Regeneron Pharmaceuticals REGN:US $ 4444.8M 2224.1M
Repligen RGEN:US $ 100.97M 17.88M
Rigel Pharmaceuticals RIGL:US $ 26.14M 54.56M
Sarepta Therapeutics SRPT:US $ 144.57M 19.99M
Teva Pharmaceutical TEVA:IT 1.92B 4M
Ultragenyx Pharmaceutical RARE:US $ 83.84M 10.37M
Vertex Pharmaceuticals VRTX:US $ 1565.4M 33.42M
YTE INCY:US $ 673.08M 92.18M
Zogenix ZGNX:US $ 17.57M 4.56M